Abstract.
Since the late 1970s, pharmaceutical R&D has grown at a rapid rate relative to sales and other variables. In this paper, we examine the determinants of pharmaceutical R&D using a pooled data sample of 11 major drug firms over the period 1974 to 1994. We find that expected returns and cash flows are important explanatory variables of firm research intensities during this period. This is consistent with our results for an earlier sample period characterized by very different growth patterns on R&D.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grabowski, H., Vernon, J. The determinants of pharmaceutical research and development expenditures. J Evol Econ 10, 201–215 (2000). https://doi.org/10.1007/s001910050012
Issue Date:
DOI: https://doi.org/10.1007/s001910050012